Containing Or Obtained From A Bark (aka Cortex) Patents (Class 424/775)
  • Patent number: 6335039
    Abstract: The present invention refers to a method for producing vasodilation or analgesia in a mammal, comprising the use of vegetal material derived from the bark of a Trichilia species.
    Type: Grant
    Filed: March 28, 2000
    Date of Patent: January 1, 2002
    Assignee: Laboratorio Catarinense S/A
    Inventors: Paulo Cezar Sander, Eduardo Augusto Moreira, Tadafissa Fujii, Zulma Raquel Vaz, Celso Shizuo Mizubuti, Roberto Mikio Kassuya, Andrea Bollmann, Aldo Piazera Junior, João Batista Calixto
  • Patent number: 6331305
    Abstract: Cosmetic compositions for topical application to the skin are in the form of a water-in-oil emulsion and comprise (a) continuous oil phase comprising a mixture of volatile silicone and non-volatile silicone; (b) discontinuous aqueous phase; and (c) willow bark extract.
    Type: Grant
    Filed: April 5, 1999
    Date of Patent: December 18, 2001
    Assignee: The Procter & Gamble Co.
    Inventor: Chune Sang
  • Patent number: 6312736
    Abstract: An herbal composition is used to relieve pain and other symptoms associated with migraines and other types of headaches. The preferred herbal composition includes white willow bark extract, kava kava root extract, feverfew extract, ginger root extract, Guarana extract, and Vitamin B6. The herbal composition may be combined with liposomes to carry the composition. The result is an herbal composition that can be applied sublingually for rapid, effective pain relief.
    Type: Grant
    Filed: December 9, 1999
    Date of Patent: November 6, 2001
    Assignee: Biotech Corporation
    Inventors: Gregory J. Kelly, Ann Perry
  • Patent number: 6312675
    Abstract: A hair cleanser of the following formula: 5.00 to 10.00% by weight aloe vera gel; 2.00 to 5.00% by weight glycerin; 1.00 to 3.00% by weight behentrimonium chloride; 1.00 to 3.00% by weight stearamidepropyl dimethyamine; 1.00 to 3.00% by weight cetyl alcohol; 1.00 to 3.00% by weight emulsifying wax; 0.10 to 1.00% by weight panthenol; 0.10 to 1.00% by weight trimethylsilylamodimethicone; 0.10 to 1.00% by weight hydrolyzed whole wheat protein 0.10 to 1.00% by weight PEG-60 almond glycerides; 0.10 to 0.50% by weight menthol; 0.10 to 0.50% by weight peppermint oil;; 0.10 to 0.50% by weight sweet almond oil; 0.10 to 0.50% by weight chamomile extract; 0.10 to 0.50% by weight cherry bark extract; 0.10 to 0.50% by weight calendula extract; 0.10 to 0.50% by weight rosemary extract; 0.10 to 0.50% by weight citric acid; 0.10 to 0.50% by weight methylchoroisothiazolinone and methyliosothiazolinone; 0.10 to 0.50% by weight fragrance; and water.
    Type: Grant
    Filed: September 14, 2000
    Date of Patent: November 6, 2001
    Inventor: Jeffrey Alan Deane
  • Patent number: 6309674
    Abstract: Prophylactic or therapeutic agents for respiratory diseases, allergic diseases, keratosis, and carcinomatous pain, containing Smilax china or a plant analogous thereto as the active ingredient. These agents can improve the condition and predisposition of acute and chronic respiratory diseases, such as acute bronchitis, bronchial asthma, asthmatic bronchitis, chronic bronchitis, pan bronchiolitis and bronchiectasis, allergic diseases, such as atopic dermatitis, pollinosis, allergic rhinitis and allergic conjunctivitis, and keratosis, such as psoriasis, lichen, ichthyosis, furfur, and palmoplantar keratosis without side effects and at the same time can lower serum IgE level on an abnormally high level in a short period of time. After the symptom and predisposition have been improved, these agents can, even after suspension of administration, persistently lower the serum IgE level and in addition can inhibit the recurrence of the symptom.
    Type: Grant
    Filed: November 19, 1999
    Date of Patent: October 30, 2001
    Assignee: Medion Research Laboratories
    Inventors: Masaya Tanaka, Masato Hiki
  • Publication number: 20010033871
    Abstract: Use of an extract derived from the fruits, the leaves, the bark or the roots of Morinda citrifolia L. for the manufacture of a medicament for the treatment of a mammal suffering from tinnitus. The extract may be a liquid present in the medicament in an amount such as to give a daily dosage of 0.1-2 ml, or 0.2-1 ml, e.g. 0.4-0.7 ml, per kg body weight of the patient. The extract also may be a solid present in the medicament in an amount such as to give a daily dosage of 5-200 mg, or 10-100 mg, e.g. 20-70 mg, per kg body weight of the patient. Optionally, the medicament also may comprise lycopene, vitamine C, coenyme Q10 and an extract from the leaves of Ginkgo biloba. The medicament may be given e.g. by oral, rectal, transdermal or inhalation administration.
    Type: Application
    Filed: March 2, 2001
    Publication date: October 25, 2001
    Inventor: Bo Gidlund
  • Publication number: 20010022981
    Abstract: The present invention is directed to a method of preparation and the composition of a water soluble extract of the plant species Uncaria. The present invention is also directed to the pharmaceutical use of the composition for the enhancement of the immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals. The present preparation of the water soluble extract of the plant species Uncaria results in the depletion of many of the ingredients which lead to various toxic side effects associated with other extracts or compositions derived from Uncaria. Also, the present preparation leads to the depletion of many of the active ingredients commonly associated with other extracts and compositions of the plant species Uncaria.
    Type: Application
    Filed: April 2, 2001
    Publication date: September 20, 2001
    Inventor: Ronald W. Pero
  • Patent number: 6264998
    Abstract: A process for isolating betulinic acid from Ziziphus jujuba is disclosed.
    Type: Grant
    Filed: March 1, 2000
    Date of Patent: July 24, 2001
    Assignee: Dabur Research Foundation
    Inventors: Sunder Ramadoss, Mohammad Jamshed Ahmed Siddiqui
  • Patent number: 6238675
    Abstract: The present invention is directed to a method of preparation and the composition of a water soluble extract of the plant species Uncaria. The present invention is also directed to the pharmaceutical use of the composition for the enhancement of the immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals. The present preparation of the water soluble extract of the plant species Uncaria results in the depletion of many of the ingredients which lead to various toxic side effects associated with other extracts or compositions derived from Uncaria. Also, the present preparation leads to the depletion of many of the active ingredients commonly associated with other extracts and compositions of the plant species Uncaria.
    Type: Grant
    Filed: November 16, 1999
    Date of Patent: May 29, 2001
    Assignee: CampaMed Corp.
    Inventor: Ronald W. Pero
  • Publication number: 20010001666
    Abstract: A composition for the maintenance of smooth, radiant, hydrated skin, including sufficient amounts of acids of hydroxyacid, to facilitate exfoliation of skin in a novel manner, without substantial irritation, as well as the prevention, treatment and management of skin conditions, such as acne, wrinkled, irregularly pigmented, photoaged, and thickened layers of the epidermis, and the like, which has as its constituents, safflower oil, flaxseed oil, sweet almond oil, apricot kernel oil, jojoba oil, organic beeswax, stearic acid, cetearyl alcohol, cocoa butter, vitamin A and tocopheral linoleate, borax, oil of lavender, and tincture of benzoin as an antimicrobial agent.
    Type: Application
    Filed: January 3, 2001
    Publication date: May 24, 2001